NCT00472368View on ClinicalTrials.gov

A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2008

Conditions
Cancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological Malignancies
Interventions
DRUG

LBH589

Trial Locations (1)

14263

Novartis Investigative Site, Buffalo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY